These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
499 related articles for article (PubMed ID: 32553712)
1. Yes-associated protein and transcriptional coactivator with PDZ-binding motif as new targets in cardiovascular diseases. Yu Y; Su X; Qin Q; Hou Y; Zhang X; Zhang H; Jia M; Chen Y Pharmacol Res; 2020 Sep; 159():105009. PubMed ID: 32553712 [TBL] [Abstract][Full Text] [Related]
2. Yes-Associated Protein and Transcriptional Coactivator with PDZ-Binding Motif in Cardiovascular Diseases. Li R; Huang W Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675179 [TBL] [Abstract][Full Text] [Related]
3. A review on decoding the roles of YAP/TAZ signaling pathway in cardiovascular diseases: Bridging molecular mechanisms to therapeutic insights. Zhang Y; Ren Y; Li X; Li M; Fu M; Zhou W; Yu Y; Xiong Y Int J Biol Macromol; 2024 Jun; 271(Pt 2):132473. PubMed ID: 38795886 [TBL] [Abstract][Full Text] [Related]
4. Hippo pathway inhibition by blocking the YAP/TAZ-TEAD interface: a patent review. Crawford JJ; Bronner SM; Zbieg JR Expert Opin Ther Pat; 2018 Dec; 28(12):867-873. PubMed ID: 30482112 [No Abstract] [Full Text] [Related]
5. Thromboxane A2 Activates YAP/TAZ Protein to Induce Vascular Smooth Muscle Cell Proliferation and Migration. Feng X; Liu P; Zhou X; Li MT; Li FL; Wang Z; Meng Z; Sun YP; Yu Y; Xiong Y; Yuan HX; Guan KL J Biol Chem; 2016 Sep; 291(36):18947-58. PubMed ID: 27382053 [TBL] [Abstract][Full Text] [Related]
6. Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway. Jang JW; Kim MK; Bae SC Small GTPases; 2020 Jul; 11(4):280-288. PubMed ID: 29457552 [TBL] [Abstract][Full Text] [Related]
7. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ). Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650 [TBL] [Abstract][Full Text] [Related]
8. YAP/TAZ for cancer therapy: opportunities and challenges (review). Guo L; Teng L Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178 [TBL] [Abstract][Full Text] [Related]
9. YAP/TAZ as mechanobiological signaling pathway in cardiovascular physiological regulation and pathogenesis. Islam R; Hong Z Mechanobiol Med; 2024 Dec; 2(4):. PubMed ID: 39281415 [TBL] [Abstract][Full Text] [Related]
10. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy. Zhu J; Wu T; Lin Q Mol Biol Rep; 2023 May; 50(5):4565-4578. PubMed ID: 36877351 [TBL] [Abstract][Full Text] [Related]
12. Effect of the acylation of TEAD4 on its interaction with co-activators YAP and TAZ. Mesrouze Y; Meyerhofer M; Bokhovchuk F; Fontana P; Zimmermann C; Martin T; Delaunay C; Izaac A; Kallen J; Schmelzle T; Erdmann D; Chène P Protein Sci; 2017 Dec; 26(12):2399-2409. PubMed ID: 28960584 [TBL] [Abstract][Full Text] [Related]
13. YAP and TAZ are transcriptional co-activators of AP-1 proteins and STAT3 during breast cellular transformation. He L; Pratt H; Gao M; Wei F; Weng Z; Struhl K Elife; 2021 Aug; 10():. PubMed ID: 34463254 [TBL] [Abstract][Full Text] [Related]
14. A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapy. Pobbati AV; Hong W Theranostics; 2020; 10(8):3622-3635. PubMed ID: 32206112 [TBL] [Abstract][Full Text] [Related]
15. Allosteric Modulation of the YAP/TAZ-TEAD Interaction by Palmitoylation and Small-Molecule Inhibitors. Mills KR; Misra J; Torabifard H J Phys Chem B; 2024 Apr; 128(16):3795-3806. PubMed ID: 38606592 [TBL] [Abstract][Full Text] [Related]
16. TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells. Finch-Edmondson ML; Strauss RP; Passman AM; Sudol M; Yeoh GC; Callus BA J Biol Chem; 2015 Nov; 290(46):27928-38. PubMed ID: 26432639 [TBL] [Abstract][Full Text] [Related]
17. Lovastatin attenuates angiotensin II induced cardiovascular fibrosis through the suppression of YAP/TAZ signaling. Wu P; Liu Z; Zhao T; Xia F; Gong L; Zheng Z; Chen Z; Yang T; Duan Q Biochem Biophys Res Commun; 2019 May; 512(4):736-741. PubMed ID: 30926167 [TBL] [Abstract][Full Text] [Related]
18. Proliferation of hepatic stellate cells, mediated by YAP and TAZ, contributes to liver repair and regeneration after liver ischemia-reperfusion injury. Konishi T; Schuster RM; Lentsch AB Am J Physiol Gastrointest Liver Physiol; 2018 Apr; 314(4):G471-G482. PubMed ID: 29351389 [TBL] [Abstract][Full Text] [Related]
19. Arterial stiffness induces remodeling phenotypes in pulmonary artery smooth muscle cells via YAP/TAZ-mediated repression of cyclooxygenase-2. Dieffenbach PB; Haeger CM; Coronata AMF; Choi KM; Varelas X; Tschumperlin DJ; Fredenburgh LE Am J Physiol Lung Cell Mol Physiol; 2017 Sep; 313(3):L628-L647. PubMed ID: 28642262 [TBL] [Abstract][Full Text] [Related]
20. Central role of Yes-associated protein and WW-domain-containing transcriptional co-activator with PDZ-binding motif in pancreatic cancer development. Rozengurt E; Eibl G World J Gastroenterol; 2019 Apr; 25(15):1797-1816. PubMed ID: 31057295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]